Airspace enlargement with fibrosis shows characteristic histology and immunohistology different from usual interstitial pneumonia, nonspecific interstitial pneumonia and centrilobular emphysema

Pathology International

Volumn 63, Issue 4, 2013, Pages 206-213

  Yamada, Tsutomu ^a   Nakanishi, Yoko ^a   Homma, Taku ^b   Uehara, Kenji ^a   Mizutani, Tomohiko ^a   Hoshi, Eishin ^c   Shimizu, Yoshihiko ^d   Kawabata, Yoshinori ^d   Colby, Thomas V ^e  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c Saitama Cardiovascular and Respiratory Center ^*  (Japan)

^d Division of Pathology   (Japan)

^e MAYO CLINIC   (United States)

Author keywords

Airspace enlargement with fibrosis; Inclusion body (Mallory body); Interstitial pneumonia; Pneumocyte injury; Ubiquitin

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRANULATION TISSUE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS CELL; LUNG EMPHYSEMA; LUNG FIBROSIS; MALE; MALLORY BODY; PRIORITY JOURNAL; PROGNOSIS; SMOKING;

AGED; BIOLOGICAL MARKERS; BIOPSY; FEMALE; GRANULATION TISSUE; HUMANS; INFLAMMATION; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PNEUMOCYTES; PNEUMONECTOMY; PULMONARY ALVEOLI; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; SMOKING; TOBACCO USE DISORDER;

EID: 84878130614     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12054     Document Type: Article

References (23)

1. Doll R, Peto R, Boreham J etal. Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 2005; 92: 426-429.
2. Raviv S, Hawkins KA, DeCamp MM Jr etal. Lung cancer in chronic obstructive pulmonary disease: Enhancing surgical options and outcomes. Am J Respir Crit Care Med 2011; 183: 1138-1146.
3. Moon J, du Bois RM, Colby TV etal. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1995; 54: 1009-1014.
4. Ryu JH, Colby TV, Hartman TE etal. Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001; 17: 122-132.
5. Kawabata Y, Hoshi E, Murai K etal. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology 2008; 53: 707-714.
6. Yousem SA. Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol 2006; 9: 1474-1479.
7. Katzenstein AL, Mukhopadhyay S, Zanardi C etal. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol 2010; 41: 316-325.
8. Wright JL, Tazelaar HD, Churg A. Fibrosis with emphysema. Histopathology 2011; 58: 517-524.
9. Washko GR, Hunninghake GM, Fernandez IE etal. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011; 364: 897-906.
10. Yamada T, Uehara K, Kawanishi R etal. Immunohistochemical detection of ubiquitin-positive intracytoplasmic eosinophilic inclusion bodies in diffuse alveolar damage. Histopathology 2006; 48: 846-854.
11. Yamada T, Uehara K, Mizutani T etal. Ubiquitin-positive pneumocytes are present in non-specific interstitial pneumonia with immunohistochemical analyses. Histopathology 2008; 53: 742-744.
12. Yamada T, Sunagawa K, Homma T etal. Ubiquitin-positive pneumocytes and inclusion bodies are present in secondary organizing pneumonia. Intern Med 2011; 50: 277-283.
13. American Thoracic Society/European Respiratory Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2002; 165: 277-304.
14. Raghu G, Collard HR, Egan JJ etal. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
15. Snider GL, Kleinerman J, Thurlbeck WM, Bengali ZH. The definition of emphysema. Report of National Heart, Lung, and Blood Institute, Division of Lung Diseases Workshop. Am Rev Respir Dis 1985; 132: 182-185.
16. Snider GL. Emphysema: the first two centuries-and beyond. A historical overview, with suggestions for future research: Part 2. Am Rev Respir Dis 1992; 146: 1615-1622.
17. Ogawa K, Mizutani T, Uehara K etal. Pathological study of pseudohypertrophy of the inferior olivary nucleus. Neuropathology 2010; 30: 15-23.
18. Basset F, Ferrans VJ, Soler P etal. Intraluminal fibrosis in interstitial lung disorders. Am J Pathol 1986; 122: 443-461.
19. Travis WD, Hunninghake G, King TE Jr etal. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008; 177: 1338-1347.
20. Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 2004; 125: 754-765.
21. Iwashita T, Kadota J, Naito S etal. Involvement of collagen-binding heat shock protein 47 and procollagen type I synthesis in idiopathic pulmonary fibrosis: contribution of type II pneumocytes to fibrosis. Hum Pathol 2000; 31: 1498-1505.
22. Amenomori M, Mukae H, Sakamoto N etal. HSP47 in lung fibroblasts is a predictor of survival in fibrotic nonspecific interstitial pneumonia. Respir Med 2010; 104: 895-901.
23. Yamada T, Satoh S, Sueyoshi S etal. Ubiquitin-positive foam cells are identified in the aortic and mitral valves with atherosclerotic involvement. J Atheroscler Thromb 2009; 16: 472-479.